URIST MARSHALL (EVP & Co-Head Research & Inv.) sold 50.0% of their position (9.10K shares) of ROYALTY PHARMA PLC on the open market
Open‑market sale worth $502.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0001838139-26-000020
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
-9.10K
Net shares
Net seller
$502.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.10K disposed
Non-Derivative Transactions1
Class A Ordinary Shares
Direct
Shares
−9.10K
Price / share
$55.18
Trade value
$502.07K
% of position
50.0%
6/24/2026
18.20K→9.10K
Total
Net shares
−9.10K
Net value
-$502.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Direct | 6/24/2026 | S · Sale | −9.10K | $55.18 | $502.07K | 50.0% | 18.20K | 9.10K |
| Total | −9.10K | -$502.07K | ||||||
Derivative Transactions0
No derivative transactions reported